These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31111288)

  • 21. Oleanolic acid alleviated pressure overload-induced cardiac remodeling.
    Liao HH; Zhang N; Feng H; Zhang N; Ma ZG; Yang Z; Yuan Y; Bian ZY; Tang QZ
    Mol Cell Biochem; 2015 Nov; 409(1-2):145-54. PubMed ID: 26215454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Celecoxib prevents pressure overload-induced cardiac hypertrophy and dysfunction by inhibiting inflammation, apoptosis and oxidative stress.
    Zhang C; Wang F; Zhang Y; Kang Y; Wang H; Si M; Su L; Xin X; Xue F; Hao F; Yu L; Xu J; Liu Y; Xue M
    J Cell Mol Med; 2016 Jan; 20(1):116-27. PubMed ID: 26512452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nifedipine inhibits cardiac hypertrophy and left ventricular dysfunction in response to pressure overload.
    Ago T; Yang Y; Zhai P; Sadoshima J
    J Cardiovasc Transl Res; 2010 Aug; 3(4):304-13. PubMed ID: 20559781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exogenous cathepsin V protein protects human cardiomyocytes HCM from angiotensin Ⅱ-Induced hypertrophy.
    Huang K; Gao L; Yang M; Wang J; Wang Z; Wang L; Wang G; Li H
    Int J Biochem Cell Biol; 2017 Aug; 89():6-15. PubMed ID: 28522343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigallocatechin gallate (EGCG) attenuates myocardial hypertrophy and fibrosis induced by transverse aortic constriction via inhibiting the Akt/mTOR pathway.
    Cui Y; Wang Y; Liu G
    Pharm Biol; 2021 Dec; 59(1):1305-1313. PubMed ID: 34607503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The transcription factor Eya2 prevents pressure overload-induced adverse cardiac remodeling.
    Lee SH; Yang DK; Choi BY; Lee YH; Kim SY; Jeong D; Hajjar RJ; Park WJ
    J Mol Cell Cardiol; 2009 Apr; 46(4):596-605. PubMed ID: 19272299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cisapride protects against cardiac hypertrophy via inhibiting the up-regulation of calcineurin and NFATc-3.
    Zhou X; Zhang Q; Zhao T; Bai X; Yuan W; Wu Y; Liu D; Li S; Ju J; Chege Gitau S; Chu W; Xu C; Lu Y
    Eur J Pharmacol; 2014 Jul; 735():202-10. PubMed ID: 24769415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A77 1726 (leflunomide) blocks and reverses cardiac hypertrophy and fibrosis in mice.
    Ma ZG; Zhang X; Yuan YP; Jin YG; Li N; Kong CY; Song P; Tang QZ
    Clin Sci (Lond); 2018 Mar; 132(6):685-699. PubMed ID: 29540538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Astragaloside IV protects against cardiac hypertrophy via inhibiting the Ca2+/CaN signaling pathway.
    Lu M; Wang H; Wang J; Zhang J; Yang J; Liang L; Maslov LN
    Planta Med; 2014 Jan; 80(1):63-9. PubMed ID: 24338553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload.
    Chen C; Zou LX; Lin QY; Yan X; Bi HL; Xie X; Wang S; Wang QS; Zhang YL; Li HH
    Redox Biol; 2019 Jan; 20():390-401. PubMed ID: 30412827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis.
    Wu MP; Zhang YS; Xu X; Zhou Q; Li JD; Yan C
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):157-166. PubMed ID: 28321644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sanguinarine protects against pressure overload‑induced cardiac remodeling via inhibition of nuclear factor-κB activation.
    Deng W; Fang Y; Liu Y; Zhou H; Cheng Z; Zhang Y; Sun D; He M; Lin Y; Zhang R; Zhang J; Li W; Tang Q
    Mol Med Rep; 2014 Jul; 10(1):211-6. PubMed ID: 24804701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allicin attenuates pathological cardiac hypertrophy by inhibiting autophagy via activation of PI3K/Akt/mTOR and MAPK/ERK/mTOR signaling pathways.
    Ba L; Gao J; Chen Y; Qi H; Dong C; Pan H; Zhang Q; Shi P; Song C; Guan X; Cao Y; Sun H
    Phytomedicine; 2019 May; 58():152765. PubMed ID: 31005720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
    Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
    Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
    Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
    Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resveratrol Attenuates Pressure Overload-Induced Cardiac Fibrosis and Diastolic Dysfunction via PTEN/AKT/Smad2/3 and NF-κB Signaling Pathways.
    Zou LX; Chen C; Yan X; Lin QY; Fang J; Li PB; Han X; Wang QS; Guo SB; Li HH; Zhang YL
    Mol Nutr Food Res; 2019 Dec; 63(24):e1900418. PubMed ID: 31655498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Puerarin attenuates pressure overload-induced cardiac hypertrophy.
    Yuan Y; Zong J; Zhou H; Bian ZY; Deng W; Dai J; Gan HW; Yang Z; Li H; Tang QZ
    J Cardiol; 2014 Jan; 63(1):73-81. PubMed ID: 23906530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced expression of DYRK1A in cardiomyocytes inhibits acute NFAT activation but does not prevent hypertrophy in vivo.
    Grebe C; Klingebiel TM; Grau SP; Toischer K; Didié M; Jacobshagen C; Dullin C; Hasenfuss G; Seidler T
    Cardiovasc Res; 2011 Jun; 90(3):521-8. PubMed ID: 21273244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resveratrol prevents chronic intermittent hypoxia-induced cardiac hypertrophy by targeting the PI3K/AKT/mTOR pathway.
    Guan P; Sun ZM; Wang N; Zhou J; Luo LF; Zhao YS; Ji ES
    Life Sci; 2019 Sep; 233():116748. PubMed ID: 31412263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-density lipoprotein inhibits mechanical stress-induced cardiomyocyte autophagy and cardiac hypertrophy through angiotensin II type 1 receptor-mediated PI3K/Akt pathway.
    Lin L; Liu X; Xu J; Weng L; Ren J; Ge J; Zou Y
    J Cell Mol Med; 2015 Aug; 19(8):1929-38. PubMed ID: 25946687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.